Retractable Technologies IncRVP
What Retractable Technologies Inc does.
Retractable Technologies, Inc. was incorporated in Texas in 1994. Our business is the manufacturing and marketing of safety medical products (predominately syringes) for the healthcare industry. We have manufacturing facilities in Little Elm, Texas and use manufacturers in China as well. Our syringes are well-suited for administering vaccinations.
On September 13, 2024, the Office of the U.S. Trade Representative (“USTR”) revealed final adjustments to increase tariffs on certain goods imported from China under Section 301 (“Section 301”) of the Trade Act of 1974 (“Trade Act”). Among those products included were syringes and needles, at a rate of 100%. Beginning in early 2025 and throughout much of the year, additional widespread tariffs were imposed on most products imported into the U.S. citing authority under the International Emergency Economic Powers Act (“IEEPA”). Those tariffs were in addition to the Section 301 tariffs which existed at the time. Throughout 2025, the prevailing tariff rates on various products and certain countries of origin, including many of our products, fluctuated greatly. These fluctuations negatively impacted our ability to predict the cost of importing certain goods or groups of goods and negatively impacted our business. In February 2026, the U.S. Supreme Court ruled that the President’s use of IEEPA to impose reciprocal tariffs exceeded his authority and that the IEEPA tariffs must be vacated. Looking forward after the Supreme Court’s ruling, the 2024 Section 301 tariff of 100% on syringes and needles from China remains unchanged. Additionally, following the Supreme Court’s ruling on the tariffs imposed under IEEPA, effective February 20, 2026 a 10% ad valorem duty went into effect under Section 122 of the Trade Act, which is in addition to the above-mentioned Section 301 tariffs.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $81.9M | $188.4M | $94.8M | $43.6M | $33.0M | $38.3M |
| Net income | $24.2M | $56.1M | $5.1M | -$7.0M | -$11.9M | -$12.6M |
| Free cash flow | -$2.1M | -$25.6M | -$61,949 | $1.9M | -$13.0M | — |
More on RVP.
- Retractable Technologies Inc summary
- Retractable Technologies Inc financial statements
- Retractable Technologies Inc key metrics
- Retractable Technologies Inc health scores and style box
- Retractable Technologies Inc earnings
- Retractable Technologies Inc dividends
- Retractable Technologies Inc valuation
- Retractable Technologies Inc ownership and insiders
- Retractable Technologies Inc peers
Figures from Retractable Technologies Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.